RATIONALE: Pathogenic T cells drive, or sustain, a number of inflammatory diseases. Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease associated with the accumulation of activated T cells. We previously demonstrated that chronic cigarette smoke (CS) exposure causes oligoclonal expansion of lung CD4(+) T cells and CD8(+) T cells in a mouse model of COPD, thus implicating these cells in disease pathogenesis. OBJECTIVES: To determine whether T cells are pathogenic in a CS-induced mouse model of COPD. METHODS: We transferred lung CD3(+) T cells from filtered air (FA)- and CS-exposed mice into Rag2(-/-) recipients. Endpoints associated with the COPD phenotype were then measured. MEASUREMENTS AND MAIN RESULTS: Here, we demonstrate that chronic CS exposure generates pathogenic T cells. Transfer of CD3(+) T cells from the lungs of CS-exposed mice into Rag2(-/-) recipients led to substantial pulmonary changes pathognomonic of COPD. These changes included monocyte/macrophage and neutrophil accumulation, increased expression of cytokines and chemokines, activation of proteases, apoptosis of alveolar epithelial cells, matrix degradation, and airspace enlargement reminiscent of emphysema. CONCLUSIONS: These data formally demonstrate, for the first time, that chronic CS exposure leads to the generation of pathogenic T cells capable of inducing COPD-like disease in Rag2(-/-) mice. This report provides novel insights into COPD pathogenesis.
RATIONALE: Pathogenic T cells drive, or sustain, a number of inflammatory diseases. Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease associated with the accumulation of activated T cells. We previously demonstrated that chronic cigarette smoke (CS) exposure causes oligoclonal expansion of lung CD4(+) T cells and CD8(+) T cells in a mouse model of COPD, thus implicating these cells in disease pathogenesis. OBJECTIVES: To determine whether T cells are pathogenic in a CS-induced mouse model of COPD. METHODS: We transferred lung CD3(+) T cells from filtered air (FA)- and CS-exposed mice into Rag2(-/-) recipients. Endpoints associated with the COPD phenotype were then measured. MEASUREMENTS AND MAIN RESULTS: Here, we demonstrate that chronic CS exposure generates pathogenic T cells. Transfer of CD3(+) T cells from the lungs of CS-exposed mice into Rag2(-/-) recipients led to substantial pulmonary changes pathognomonic of COPD. These changes included monocyte/macrophage and neutrophil accumulation, increased expression of cytokines and chemokines, activation of proteases, apoptosis of alveolar epithelial cells, matrix degradation, and airspace enlargement reminiscent of emphysema. CONCLUSIONS: These data formally demonstrate, for the first time, that chronic CS exposure leads to the generation of pathogenic T cells capable of inducing COPD-like disease in Rag2(-/-) mice. This report provides novel insights into COPD pathogenesis.
Authors: Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Erin E West; Matthew H Willett; Martin F Britos; Matthew R Pipeling; Roy G Brower; Rubin M Tuder; John F McDyer; Landon S King Journal: J Clin Invest Date: 2009-09-21 Impact factor: 14.808
Authors: Amrita D Joshi; Daniel J Fong; Sameer R Oak; Glenda Trujillo; Kevin R Flaherty; Fernando J Martinez; Cory M Hogaboam Journal: Am J Respir Crit Care Med Date: 2009-01-16 Impact factor: 21.405
Authors: Christine M Freeman; Fernando J Martinez; MeiLan K Han; Theresa M Ames; Stephen W Chensue; Jill C Todt; Douglas A Arenberg; Catherine A Meldrum; Christi Getty; Lisa McCloskey; Jeffrey L Curtis Journal: Am J Respir Crit Care Med Date: 2009-09-03 Impact factor: 21.405
Authors: Michael T Borchers; Scott C Wesselkamper; Victor Curull; Alba Ramirez-Sarmiento; Albert Sánchez-Font; Judith Garcia-Aymerich; Carlos Coronell; Josep Lloreta; Alvar G Agusti; Joaquim Gea; John A Howington; Michael F Reed; Sandra L Starnes; Nathaniel L Harris; Mark Vitucci; Bryan L Eppert; Gregory T Motz; Kevin Fogel; Dennis W McGraw; Jay W Tichelaar; Mauricio Orozco-Levi Journal: J Clin Invest Date: 2009-02-09 Impact factor: 14.808
Authors: A Di Stefano; G Caramori; A Capelli; I Gnemmi; F L Ricciardolo; T Oates; C F Donner; K F Chung; P J Barnes; I M Adcock Journal: Eur Respir J Date: 2004-07 Impact factor: 16.671
Authors: Carlotta Nannini; Yimy F Medina-Velasquez; Sara J Achenbach; Cynthia S Crowson; Jay H Ryu; Robert Vassallo; Sherine E Gabriel; Eric L Matteson; Tim Bongartz Journal: Arthritis Care Res (Hoboken) Date: 2013-08 Impact factor: 4.794
Authors: Hui Bi; Ji Zhou; Dandan Wu; Wei Gao; Lingling Li; Like Yu; Feng Liu; Mao Huang; Ian M Adcock; Peter J Barnes; Xin Yao Journal: Inflamm Res Date: 2014-12-27 Impact factor: 4.575
Authors: Huan Liu; Andrew R Osterburg; Jennifer Flury; Shuo Huang; Francis X McCormack; Stephania A Cormier; Michael T Borchers Journal: J Infect Dis Date: 2018-10-20 Impact factor: 5.226
Authors: Huan Liu; Andrew R Osterburg; Jennifer Flury; Zulma Swank; Dennis W McGraw; Nishant Gupta; Kathryn A Wikenheiser-Brokamp; Ashish Kumar; Abdellatif Tazi; Yoshikazu Inoue; Masaki Hirose; Francis X McCormack; Michael T Borchers Journal: JCI Insight Date: 2020-02-27